1st University of Illinois Hospital & BTF Telemedicine Specialty Review Course in: Hematologic Malignancies: A patient-specific approach in diagnostic and therapeutic procedures
Jan 2013 – May 2013
Damiano Rondelli, MD – Binaytara Foundation & Section of Hematology-Oncology, University of Illinois Hospital & Health Sciences System, Chicago, IL, USA
Timothy Erickson, MD – Center for Global Health, University of Illinois Hospital & Health Sciences System, Chicago, IL, USA
Dinesh Pendharkar, MD, PhD – S.L.Raheja- Fortis Hospital, Mumbai, India
Overview: This educational program will provide physicians from developing countries with an overview of recent advances in the management of hematologic malignancies. Upon satisfactory completion of the review course, participants will be awarded completion certificate from University of Illinois and Binaytara Foundation
Jan 11, 2013 (Friday) – Old and new drugs in Hematologic Malignancies by Karen Sweiss, PharmD
Jan 18, 2013 (Friday) – Chronic Myeloid Leukemia by Prof. Divyesh Mehta
Feb 8, 2013 (Friday) – Low Grade Lymphoma by Dr. Binay Shah
Feb 15, 2013 (Friday) – Chronic Lymphocytic Leukemia by Dr. Dinesh Pendharkar
Mar 1, 2013 (Friday) – Hodgkin’s Lymphoma by Dr. Abdur Shakir
Mar 15, 2013 (Friday) – Myelodysplastic syndrome by Dr. Damiano Rondelli
Mar 29, 2013 (Friday) – High Grade Lymphoma by Dr. David Peace
Apr 12, 2013 (Friday) – Ph negative MPDs by Dr. Damiano Rondelli
Apr 26, 2013 (Friday) – Blood and Bone marrow stem cell transplant by Dr. Damiano Rondelli
May 3, 2013 (Friday) – Multiple Myeloma by Dr. Pritesh Patel
May 10, 2013 (Friday) – Acute Lymphoblastic Leukemia by Dr. John Quigley
May 24, 2013 (Friday) – Acute Myeloid Leukemia by Dr. Santosh Saraf
Karen Sweiss, PharmD,
Clinical Assistant Professor, Department of Pharmacy practice, University of Illinois, Chicago
Dr. Divyesh Mehta
Professor Of Medicine, University Of Arizona College Of Medicine,
Chief, Hematology Oncology Division, Maricopa Integrated Health System, Phoenix, AZ
Dr. Mehta is a Professor of Medicine at University of Arizona College of Medicine. Dr. Mehta has research interest in Triple Negative Breast Cancer and Multi modality treatment of Hepatocellular Carcinoma.
Dr Mehta received his MD from Medical College in Baroda, India. Subsequently, he completed two internships, one at SSG Hospital in Baroda and one at St. Mary of Nazareth Hospital in Chicago. These were followed by an internal medicine residency at Louis A. Weiss Memorial Hospital in Chicago and a hematology/oncology fellowship at the University of Illinois.
He pioneered several efforts in India including setting up Western India’s first comprehensive component blood bank at Children’s Hospital in Baroda and helping to found the Indian Cooperative Oncology Network, which focuses on cancer research. Dr Mehta has authored 3 book chapters; the most recent is titled “Platelet Disorders” for the 2003 edition of the API Textbook of Medicine.
Dr. Damiano Rondelli
Professor of Medicine and Director of Stem Cell Transplant Program at University of Illinois
Dr. Damiano Rondelli is a Professor of Medicine and Director of Stem Cell Transplant Program at the University of Illinois at Chicago. His clinical research focuses on allogeneic stem cell transplantation. In particular, his interest has been on the use of i.v. busulfan in transplant conditioning regimens, stem cell transplantation in myelofibrosis and identification of biomarkers of acute and chronic GVHD by flow cytometry. His laboratory focuses on in-vitro and in-vivo models of T cell alloreactivity against hematopoietic stem cells and translational strategies to overcome it.
Dr. Rondelli serves as a member of the International Myeloproliferative Disorders Research Consortium (MPD-RC), funded by an NCI PO1 grant (PI Ronald Hoffman, MD) where he chairs a study using a reduced intensity conditioning regimen in allogeneic stem cell transplantation for patients with myelofibrosis.
Dr. Rondelli has published over 90 full-papers in international peer-reviewed journals including Blood, Leukemia, Biology Blood Marrow Transplantation, and is a co-author of an Italian Hematology textbook. “Lezioni di Ematologia” by Sante Tura et al, Esculapio Bologna, 2003. He is a reviewer of many esteemed journals including Blood, Cancer research, American Journal of Transplantation, etc.
Dr. Rondelli received his medical degree with honors from the University of Bologna, Italy. After completing School of specialization in hematology at the University of Bologna, he worked as research associate at the Fred Hutchinson Cancer Research Center, Seattle, WA where he started his studies on the antigen presenting function of CD34+ hematopoetic stem cells.
Dr. Dinesh Pendharkar
Dr. David Peace
Professor of Medicine, University of Illinois
Dr. Abdur Shakir
Assistant Professor of Medicine, University of Illinios
Dr. Shakir was born and raised in Chicago and at a young age he knew wanted to study medicine. He discovered his love of medicine working next to his father an anesthesiologist. To keep busy during his summer months he would work along his father and during that time he knew he wanted to become a physician.
Receiving his medical degree in 2002, he moved to Cincinnati, Ohio, to begin a residency in internal medicine at Jewish Hospital of Cincinnati. He received honors as Intern of the Year during his first year, and Senior Resident of the Year the next.
Passionate in the study of cancer, he also completed fellowship in Neuro-Oncology where he cared for people with brain tumors at Henry Ford Hospital in Detroit, Michigan.
Seeing and studying some of the most devastating brain tumors, Dr. Shakir said he learned the most from his interaction with the people he cared for and their families. Though extremely challenging, he also found it rewarding and was thankful to offer hope to many, with treatment options continuing to improve. During his fellowship he also wrote clinical trials and helped develop protocols for treatment. The fellowship is part of the “New Approaches to Brain Tumor Therapy” (NABTT) Consortium, which aims to improve outcomes for adults with primary brain tumors by offering the newest and most advanced treatments in the country.
Seeking additional research in cancer care, Dr. Shakir then began his second fellowship Chicago. Studying general hematology and oncology during his second fellowship, he gained vast experience treating a large number of people suffering from many different types of cancer, also being involved in stem cell transplant. Dedicated to the academics Dr.Shakir published and presented his work at the American Society of Clinical Oncology Meetings. During his 3rd year he was nominated as the Chief Hematology Oncology Fellow bestowed to only one fellow in his class per year.
Dr.Shakir was appointed the Director of the Sarah Bush Lincoln Cancer Center on August 1st 2010. Compassion is fundamental to good care, the Hematologist/Oncologist said upon joining the Sarah Bush Lincoln Regional Cancer Center in August. “Having open communication with the people I care for and their families, addressing their fears and concerns, and answering their questions is vital in this field of medicine. It’s the best place to start.” In addition, he serves as an assistant professor in Hematology/Oncology at the University of Illinois at Chicago, keeping him in close for the latest advances in the field.
Dr. John Quigley
Assistant Professor of Medicine, University of Illinois
Dr. Binay Shah
Hematologist and Medical Oncologist, St. Joseph Regional Medical Center, Lewiston ID
Dr. Binay Shah is a consultant hematologist and oncologist at St. Joseph Regional Medical Center, Lewiston, Idaho. Dr. Shah received his medical degree from BP Koirala Institute of health Sciences, Dharan, Nepal. He completed Internal Medicine residency from Long Island College Hospital, Brooklyn and Hematology Oncology fellowship from University of Illinois at Chicago. He has presented several abstracts in National Hematology/Oncology conferences. He has authored a number of scientific papers in prestigious journals like Journal of Clinical Oncology, British Journal of Hematology, Acta Oncologica, Annals of Hematology among others. He is a founding editor of Journal of Advances in Internal Medicine. He serves on the board of Idaho Society of Clinical Oncology.
You may contact Dr. Dinesh Pendharkar (firstname.lastname@example.org) if you have any questions about registration.
Registration fee: 20 USD